Background Comprehensive genetic approaches for diagnosing inherited kidney diseases using next-generation sequencing (NGS) have recently been established. However, even with these approaches, we are still failing to detect gene defects in some patients who appear to suffer from genetic diseases. One of the reasons for this is the difficulty of detecting copy number variations (CNVs) using our current approaches. For such cases, we can apply methods of array-based comparative genomic hybridization (aCGH) or multiplex ligation and probe amplification (MLPA); however, these are expensive and laborious and also often fail to identify CNVs. Here, we report seven cases with CNVs in various inherited kidney diseases screened by NGS pair analysis. Methods Targeted sequencing analysis for causative genes was conducted for cases with suspected inherited kidney diseases, for some of which a definitive genetic diagnosis had not been achieved. We conducted pair analysis using NGS data for those cases. When CNVs were detected by pair analysis, they were confirmed by aCGH and/or MLPA. Results In seven cases, CNVs in various causative genes of inherited kidney diseases were detected by pair analysis. With aCGH and/or MLPA, pathogenic CNV variants were confirmed: COL4A5 or HNF1B in two cases each, and EYA1, CLCNKB, or PAX2 in one each. Conclusion We presented seven cases with CNVs in various genes that were screened by pair analysis. The NGS-based CNV detection method is useful for comprehensive screening of CNVs, and our results revealed that, for a certain proportion of cases, CNV analysis is necessary for accurate genetic diagnosis.
Introduction
A comprehensive genetic approach using next-generation sequencing (NGS) of all causative genes for inherited kidney diseases has been established. Whole-exome sequencing or targeted sequencing improves the efficiency of diagnosing inherited kidney diseases [1] by providing simultaneous analysis of all relevant genes for a given phenotype, at a much lower cost and with a shorter turnaround time than when sequentially testing one gene after another. Targeted sequencing panels are especially useful for analyzing diseases with genetic heterogeneity, such as Bartter syndrome or steroid-resistant nephrotic syndrome, which have many different causative genes [2, 3] .
Recent studies have indicated that copy number variants (CNVs) are widespread in the human genome and are a significant source of genetic variation accounting for disease and population diversity [4] . The detection of CNVs in clinical laboratories has conventionally relied on techniques such as karyotype analysis of G-banding or, recently, array-based comparative genomic hybridization (aCGH) 1 3 for genome-wide CNV detection, and multiplex ligation and probe amplification (MLPA) or fluorescence in situ hybridization for the detection of CNVs in specific genes or regions [5] .
The NGS-based CNV detection methods can be categorized into five different strategies: (1) paired-end mapping; (2) split read; (3) read depth; (4) de novo assembly of a genome; and (5) a combination of these approaches. According to a recent report, an NGS-based CNV detection method had 92% sensitivity and 100% specificity to detect deletions as small as 180 bp and duplications as small as 300 bp in specific targeted gene panels [6] .
For inherited kidney diseases, some different studies have been particularly highlighted on the existence of CNVs in congenital anomalies of the kidney and urinary tract (CAKUT) causative genes [7] [8] [9] . Otherwise, there is a paucity of material on CNVs involved in hereditary kidney diseases. To bridge this research gap, this paper presents seven cases in which CNVs were successfully detected by pair analysis in various hereditary kidney diseases.
Materials and methods

Genetic analysis
Genomic DNA was isolated from peripheral blood leukocytes from patients and their family members using the Quick Gene Mini 80 system (Wako Pure Chemical Industries, Ltd., Tokyo, Japan), in accordance with the manufacturer's instructions. Targeted sequencing using next-generation sequencing (NGS) was conducted for genes responsible for inherited renal disease. The gene list included in the panel is shown in Supplementary Table 1. NGS samples were prepared using a HaloPlex target enrichment system kit (Agilent Technologies, Santa Clara, CA), in accordance with the manufacturer's instructions. Briefly, 225 ng of genomic DNA was used for a restricted reaction and hybridized at 54 °C for 16 h with NGS probes. All indexed DNA samples were amplified by polymerase chain reaction and sequenced using the MiSeq platform (Illumina, San Diego, CA). We analyzed the data using SureCall 4.0, which is a desktop application combining algorithms for end-to-end NGS data analysis from alignment to categorization of mutations (Agilent Technologies). We show coverage of targeted genes in Supplementary Table 2 .
Pair analysis
To determine copy number changes in a sample relative to a reference that does not have a copy number change, we used pair analysis by SureCall. For the CNV detection algorithm that SureCall uses in pair analysis workflows, the user specifies the paths to the sample BAM file containing possible CNVs and a diploid reference BAM file. The algorithm uses intervals defined in the analyzable target bed file. With adaptive interval sizing turned on, analyzable target intervals that are longer than the userdefined interval sizes are broken into smaller intervals. The per base read depth coverage of each interval is computed for both sample and reference BAM files. Average interval read depths are computed using the per base coverage values. The overall average read depth is computed for sample and reference. The average interval read depths are normalized to the respective overall average sample and reference read depths. Intervals with normalized read depths greater than the user-defined threshold in both sample and reference are used in the CNV analysis. The log2 ratio of the sample to the reference is computed and used for predicting aberration intervals. Aberration intervals are identified using a method called total variation regularization, which is based on smoothing away noise in flat regions whilst preserving sharp changes. The model uses a regularization parameter that impacts the ability to detect a point of change between two adjacent intervals. After iterating through a range of regularization values, the final results are prioritized based on the number of times a point of change has been detected (referred to as Score in Triage view) and the average read depth of the interval. We decided to conduct further aCGH or MLPA analysis only when the consequent exons (more than two exons) come out as a deletion and the deleted genes were consistent with the patients' clinical presentations. To confirm the pathogenicities of entire gene deletions detected in this study, we checked the HGMD database (http:// www.hgmd.cf.ac.uk/) describing entire gene deletions as disease causing.
Multiplex ligation probe amplification
We performed multiplex ligation probe amplification (MLPA) using SALSA P153 for EYA1, P191/192 for COL4A5, P266 for CLCNKB, and P357 for HNF1B, as suggested by the manufacturer (MRC-Holland, Amsterdam, Netherlands). The MLPA test was performed twice for the confirmation of abnormal changes. Briefly, 50-100 ng of genomic DNA in 5 µL of deionized water was denatured and hybridized overnight with the probe mix. Ligation was performed with the SALSA Ligase 65 enzyme and finally polymerase chain reaction (PCR) amplification was performed with the SALSA PCR Primer Mix. Amplification products and Size Standard 600 were mixed thoroughly and subjected to capillary electrophoresis on Gene Mapper v.3.7 (Thermo Fisher, Waltham, MA, USA). 
Results
Patients (Table 1)
Patient 1 was a 47-year-old Japanese male. At 32 years of age, he had been started on hemodialysis in an emergency associated with an unknown disease. He had hearing loss and auricular pits. Alport syndrome was suspected based on the clinical presentation and skin biopsy was performed. However, immunofluorescence staining for alpha 5 chains of type IV collagen showed normal expression, which was evidence against a diagnosis of X-linked Alport syndrome. Regarding the family history, his father had proteinuria, deafness, and auricular pits without renal dysfunction or ocular abnormalities.
We conducted targeted sequencing, but revealed no pathogenic variants. Next, we conducted pair analysis. The results demonstrated copy number changes in the EYA1 gene and showed deletion of the EYA1 gene in the patient and his father, which was confirmed by MLPA (Fig. 1A) .
Patient 2 was a 4-year-old girl. At 3 years of age, she had been referred to hospital because of hematuria and proteinuria, which had been identified by a urine screening system routinely performed at this age. She had no clinically detectable hearing loss or ocular abnormalities. There was no family history for kidney disease. She had no kidney dysfunction or hypoalbuminemia. Urinalysis showed urine protein of 0.25 g/gCr and 3+ hematuria with the urine sediment containing > 100 red cells per high-power field. Her hematoproteinuria was sustained and she suffered from two episodes of macroscopic hematuria, so she underwent a renal biopsy. Pathologically, light microscopy demonstrated focal mesangial proliferative glomerular nephritis and electron microscopy demonstrated basket-wave glomerular basement membrane GBM change. Immunofluorescence staining for alpha 5 chains of type IV collagen showed a segmental and mosaic pattern in the GBM.
We conducted targeted sequencing analysis using NGS. However, the analysis revealed no mutation. Next, we conducted pair analysis, the result of which demonstrated copy number changes in exons 14-19 of the COL4A5 gene. MLPA confirmed exactly the same deletion of the COL4A5 gene in the patient (Fig. 1B) .
Patient 3 was a 4-month-old boy. His birth weight was 2670 g at 41 weeks' gestation. At 3 months of age, he was found to have hypokalemia and metabolic alkalosis and was diagnosed with Bartter syndrome. At 4 months of age, he showed prominent growth retardation (height, − 2.3 SD; weight − 2.6 SD). Laboratory findings were as follows: serum potassium, 2.1 mmol/L; magnesium, 2.1 mg/dL; and calcium, 11.4 mg/dL. The urine calcium to creatinine ratio was 0.04. Pronounced metabolic alkalosis was identified, with plasma pH of 7.597 and bicarbonate of 44.6 mmol/L. We conducted targeted sequencing analysis using NGS and found that the patient was carrying CLCNKB monoallelic variants. The variants involved a homozygous G to A substitution at base position 1830 in exon 16, which introduces a preliminary stop codon at position 610 (p.TrpW610*). The patient's mother carried this variant in heterozygous form, but his father did not ( Supplementary  Fig. 1 ). Therefore, we conducted pair analysis and showed that, in the case and his father, there was heterozygous deletion of the CLCNKB gene. MLPA analysis confirmed the total deletion of the CLCNKB gene (Fig. 1C) .
Patient 4 was a 62-year-old woman. The family tree is shown in Supplementary Fig. 2 . At 52 years old, low serum Mg and K levels were detected by chance in her second daughter after she had suffered an asthma attack. Laboratory findings of patient 4's second daughter ( Supplementary  Fig. 2 . II.2) were as follows: serum potassium, 2.8 mmol/L; and magnesium, 0.6 mg/dL. The patient 4 and her family underwent blood tests at the same time, which also revealed hypomagnesemia and hypokalemia. Laboratory findings were as follows: serum potassium, 2.9 mmol/L, and magnesium, 0.8 mg/dL, for patient 4; serum potassium, 2.8 mmol/L, and magnesium, 0.9 mg/dL, for her first daughter ( Supplementary Fig. 2 . II.1); and serum potassium, 3.4 mmol/L, and magnesium, 1.3 mg/dL, for her son (Supplementary Fig. 2. II.3 ). They were diagnosed with Gitelman syndrome and were prescribed potassium and magnesium from that time. However, patient 4's medical history also included diabetes, kidney cysts, and a suspicion of primary sclerosing cholangitis. Her first daughter ( Supplementary  Fig. 2 .II.1) had diabetes, right-side polycystic kidney, leftside hypoplastic kidney, mental retardation, and gallbladder adenomyomatosis. Her second daughter ( Supplementary  Fig. 2 . II.2) and her son ( Supplementary Fig. 2 . II.3) also had mental retardation and liver disease, including elevated aspartate aminotransferase and alanine aminotransferase.
We conducted targeted sequencing analysis using NGS, which revealed no mutation. Next, we conducted pair analysis, the result of which demonstrated copy number changes in the HNF1B gene. Exhaustive mutation analysis of the HNF1B gene was carried out by MLPA, which showed deletion of this gene in the patient, her first daughter, second daughter, and son (Fig. 1D) . aCGH of the patient revealed copy number reduction due to deletion in chromosome 17q12, which contained 12 genes ( Fig. 2A) . Genes encompassed in this interval were LHX1, AATF, MIR2909, ACACA, SNORA90, C17orf78, TADA2A, DUSP14, SYNRG, DDX52, MIR378J, and HNF1B. Based on these findings, the diagnosis of 17q12 deletion syndrome was made.
Patient 5 was a 31-year-old woman. At 12 years of age, she was referred to hospital because of proteinuria, which had been identified in a school-based urine screening system. She had amblyopia of the right eye. Her serum creatinine level was 0.9 mg/dL and urinalysis showed a urinary protein level of 0.9 g/gCr, so she underwent a renal biopsy. Light microscopy demonstrated oligomeganephronia. At 31 years of age, her blood urea nitrogen level was 54.8 mg/dL, serum creatinine level was 1.51 mg/dL (eGFR 34.4 mL/min/1.73 m 2 ), and albumin level was 4.0 mg/dL. Urinalysis showed a urinary protein level of 5.1 g/gCr. Renal ultrasonography revealed multiple cysts and reduced size of both kidneys. Her mother had a history of hypertension, renal cysts, and renal dysfunction (eGFR 62.8 mL/ min/1.73 m 2 ). We conducted targeted sequencing analysis using NGS, which revealed no mutation. Next, we conducted pair analysis, which demonstrated copy number changes in the PAX2 gene. The results of the patient's aCGH revealed a 2.7 Mb reduction of copy number in chromosome 10q24, which contained the PAX2 gene (Fig. 2B) .
Patient 6 was a 43-year-old man. He had been shown to exhibit low serum Mg 2+ , Na + , Ca 2+ , and K + when affected by subileus. This patient and his family underwent blood tests at the same time, which also revealed hypomagnesemia and hypokalemia. He was clinically diagnosed with Bartter syndrome. His medical history also included diabetes, cholecystolithiasis, and schizophrenia. His father, grandfather, and two paternal uncles had diabetes. Laboratory findings were as follows: serum potassium, 2.4 mmol/L; magnesium, 0.7 mg/dL; and calcium, 5.9 mg/ dL. The urine calcium to creatinine ratio was 0.0258.
We conducted targeted sequencing analysis using NGS, including of hereditary renal disease-causative genes, which revealed no mutation. Next, we conducted pair analysis, which demonstrated copy number changes in the HNF1B gene. Exhaustive mutation analysis of the HNF1B gene was carried out by MLPA, which showed deletion of this gene in the patient (Fig. 1E) . aCGH for the patient revealed a reduction in copy number in chromosome 17q12 (Fig. 2C) .
Patient 7 was a 5-year-old girl. At 3 years of age, she was referred to hospital because of proteinuria, which was identified by a urine screening system routinely performed at this age. She had no clinically detectable hearing loss or ocular abnormalities. Her hematoproteinuria was sustained, so she underwent renal biopsy. Her blood urea nitrogen level was 23.7 mg/dL, serum creatinine level was 0.28 mg/dL, and albumin level was 4.1 mg/dL. Urinalysis showed a urinary protein level of 0.1 g/gCr. Light microscopy demonstrated focal mesangial proliferation glomerulonephropathy. Electron microscopy demonstrated basket-wave GBM change.
We conducted targeted sequencing analysis using NGS, which revealed no mutation. Next, we conducted pair analysis, which demonstrated copy number changes in the COL4A5 gene. MLPA showed deletion of exons 2-36 in the COL4A5 gene of the patient (Fig. 1F) .
Discussion
NGS is a technique that involves the massively parallel sequencing of many DNA molecules at once [10] . For NGS panels to be effective in a clinical setting, all variant classes need to be robustly detected. The detection of small insertions and deletions is improving, but accurate detection of deletions or duplications of whole exons, also known as exon copy number variants (exon CNVs), has proved problematic in targeted NGS data, particularly the detection of single-exon CNVs [11] . Recently, NGS has become capable of sensitively detecting sequence variants and may also be used for the detection of CNVs, such as exon deletions and duplications that currently require the use of MLPA or other copy number technologies. In this context, this paper presents seven cases with the aim of clarifying CNVs in hereditary kidney diseases screened by pair analysis using NGS data.
Several notable findings were made from these seven case reports, which are presented below. First, patients 2 and 7 met the clinical diagnostic criteria for Alport syndrome; however, the result of NGS panel analysis was negative. Fortunately, the suspected CNVs could actually be diagnosed by CNV analysis. In Alport syndrome, a total of 1168 unique COL4A5 variants have been identified, including 76 complex mutations or deletions of more than 26 nucleotides (7%), 55 insertions (5%), 13 duplications (1%), 169 short deletions (with fewer than 26 nucleotides, 14%), 16 indels (1%), 73 nonsense mutations (6%), 504 missense variants (43%), and 273 (23%) splicing variants, along with 25 copy number variations [12] . Although they are relatively rare, we should not overlook the possibility of cases involving CNVs, which could have been missed in those previously subjected to NGS panel analysis.
Second, patients 4 and 6 had hypokalemia, so clinically Bartter syndrome was suspected. However, both cases were diagnosed with chromosome 17q11.2 deletion syndrome. When a large deletion was suspected, CNV analysis proved to be a clue to diagnosis. Because NGS is cheaper than aCGH, for patients with systemic symptoms, it is useful to perform NGS panel analysis. With CAKUT, a major molecular determinant of kidney malformations, a monogenic gene defects account for up to 17% of patients [7] . If we use this method of detecting CNVs by pair analysis using NGS data, there is a possibility that the diagnosis rate will rise more in CAKUT.
Third, even if a homozygous mutation appears to be present, as in patient 3, this can actually involve a case of complex heterozygosity with compound heterozygous deletion. The mutations in the CLCNKB gene encoding the ClC-Kb chloride channel are responsible for Bartter syndrome type 3 which inheritance mode is autosomal recessive. One characteristic feature of this disease is the frequent occurrence of total CLCNKB gene deletion [13] . Thus, as in this case, we also suggest that CNV analysis be performed in cases of an apparently homozygous mutation, due to the high possibility of them indeed featuring heterozygous large deletions.
Fourth, patient 1 was clinically suspected of having Alport syndrome. However, he was finally diagnosed with branchio-oto-renal (BOR) syndrome. Since Alport syndrome and BOR syndrome have different inheritance modes, it is important to obtain an accurate diagnosis. Accurate diagnosis is advantageous in genetic counseling [14] .
With NGS data, there are a number of ways to detect CNVs, including assembly (complete de novo or using unmapped reads only), read splitting, read coverage depth analysis, and inconsistencies of insert sizes through pairedend mapping. Among these, de novo assembly from short reads may offer the best opportunity to identify long indels and structural rearrangements [15] .
There is a limitation in our current study because the specificity of detecting CNVs by pair analysis is relatively low. For example, among cases clinically diagnosed with Alport syndrome, CNVs were suspected in ten cases by pair analysis. Among them, CNVs were detected only in six by MLPA. Furthermore, we have not investigated the sensitivity of pair analysis in our cases and this should be revealed in the future.
Conclusion
NGS has allowed the simultaneous detection of singlenucleotide variants, insertions/deletions (indels), and CNVs in a single assay. As its accuracy increases, the increasing application of CNV analysis in hereditary kidney disease is important for accurate diagnosis.
